about
Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cellsSmoking initiation is followed by the early acquisition of epigenetic change in cervical epithelium: a longitudinal study.Fas-associated factor (Faf1) is a novel CD40 interactor that regulates CD40-induced NF-κB activation via a negative feedback loop.Genome diversity of Epstein-Barr virus from multiple tumor types and normal infectionThe Epstein-Barr virus encoded LMP1 oncoprotein modulates cell adhesion via regulation of activin A/TGFβ and β1 integrin signalling.The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigensSouth Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's diseaseSeasonal differences in the onset of the EBV-positive and -negative forms of paediatric Hodgkin's lymphoma.Mechanism of cell death induced by the novel enzyme-prodrug combination, nitroreductase/CB1954, and identification of synergism with 5-fluorouracilEpstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma.Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.Epstein-Barr virus: more than 50 years old and still providing surprises.The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation.Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector.Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells.Epstein-Barr virus at 50-future perspectives.The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype.Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.The effect of Epstein-Barr virus status on outcome in age- and sex-defined subgroups of patients with advanced Hodgkin's disease.Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma.Gene therapy for hepatocellular carcinoma-teaching old dogs new tricks.The EBV-Encoded Oncoprotein, LMP1, Induces an Epithelial-to-Mesenchymal Transition (EMT) via Its CTAR1 Domain through Integrin-Mediated ERK-MAPK Signalling.Epstein-Barr virus and nasopharyngeal carcinomaThe Dynamic Roles of TGF-β Signalling in EBV-Associated CancersFrequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomasEpstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomasA novel Epstein-Barr virus subtype associated with nasopharyngeal carcinoma found in South ChinaPhotoactive platinum(iv) complex conjugated to a cancer-cell-targeting cyclic peptideAn etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma
P50
Q29303134-B6B4CB3A-D1F2-4725-A743-922399B3A8BAQ35006883-348D2A51-786E-46C7-BB76-A4048940C9B7Q35165371-B9B892B7-4610-4942-8A58-C3ED1BFCAC54Q35641421-BF892D02-60D7-4D09-AFE0-2C4338531E78Q36500037-D1603D74-C3D1-4464-9941-6B7D69CC17F7Q36611909-4DB29B0D-FAFA-4FC4-B8B4-53A91F1823A5Q36623552-35762B5C-4D7E-448F-9FBC-DC65EDFF10FAQ36671047-EA631BC7-68A7-47B4-B788-A5D2BBEC60E1Q36671725-A780EC5C-9894-4ADC-8C7E-FAF7923A19C4Q37623910-1A551841-3DF7-4BF3-96BA-DD6EA33898F4Q38861579-C1D6907E-C6F2-4D6B-AA58-49A0ED25E968Q38968588-1D991579-25F1-4ADF-B00A-58B87F00D62AQ39806231-DE602E6B-12F9-4AB6-9D7F-E2315DE3698DQ40440798-AC2E1D41-DBB6-4FA6-815C-AE1EC46CDDF1Q40551469-85EFB389-8B3E-4A1E-B8AD-DCDDD7631664Q40870857-C1E2B03C-2934-4A3B-852E-4535F20961E3Q43035017-72E68738-AD00-4AB2-8A0B-9B14FA89C290Q43808409-3D0EDF13-AAA8-4C33-964F-FD00AE582CDDQ45656306-46E90DAA-AD55-4DA0-8715-C6DABA56CB9BQ45729298-32BFFE80-2B27-4820-A654-9BADF9A92D0BQ45867029-0158D6A3-D6EC-488D-B232-40C8296E86C8Q45878278-1184ED84-67E6-49F3-85A5-93DC584487FFQ54112589-BF21D17B-CF75-4FCE-9D46-AC6069B2CDACQ56947843-B33AA800-DFED-46C0-9E70-4285CB931317Q59355701-79A4894A-CEEB-44DA-A255-4D89F471AE91Q74538934-F64455C9-324A-4321-BC43-4CF7DA71290CQ89292967-C5052DD1-D761-4FAC-B86E-7617EC03FD46Q89798467-3EE607AB-F661-4D06-A695-E50045C8A13AQ92419884-C0DFA73D-78C0-425C-920D-F37E865E3FEEQ92665885-5B7AC781-B600-41B7-8B55-03C6B8C001FD
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lawrence S Young
@ast
Lawrence S Young
@en
Lawrence S Young
@es
Lawrence S Young
@nl
type
label
Lawrence S Young
@ast
Lawrence S Young
@en
Lawrence S Young
@es
Lawrence S Young
@nl
prefLabel
Lawrence S Young
@ast
Lawrence S Young
@en
Lawrence S Young
@es
Lawrence S Young
@nl
P106
P31
P496
0000-0003-3919-4298